Not wanting to seem a downramper, but personally see some drawbacks to ANP presently. 1.5 b shares being all of them. Large scale-back/consolodation I see as a must before the next CR, which will at some stage be needed. Nice IP to work with, but the bio cash burn has hurt this ones potential. I like it, but will remain on watchlist for the time being. Just my opinion..all the best with it.
Regards,meg
spp at 1.8c, page-61
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
